Pantech Biosolutions Raises $19 Million
Pantech Biosolutions AG, a Liechtenstein-based developer of transdermal delivery solutions for large-molecular weight drugs, has raised CHF20 million($19m) led by StemCell Holding AG. The company previously raised CHR 6.3 million in Series A funding led by Gamma Capital Partners.
20 July 2010•3 mins read
